Skip to Main Content
Back to News

Lobbying Update: $430,000 of SMITH & NEPHEW INC. lobbying was just disclosed

None

$430,000 of SMITH & NEPHEW INC. lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. H.R. 9157 / S.5275, Access to Pediatric Technologies Act of 2024. Issues related to the base erosion and anti-abuse tax. Issues related to the employee retention tax credit. H.R. 7024, Tax Relief for American Families and Workers Act of 2024; Issues related to the amortization of R&D expense & Issues related to the deduction of interest expense. Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act. Issues related to section 301 tariffs. Issues related to H.R.8333 - BIOSECURE Act."

You can find more data on corporate lobbying on Quiver Quantitative.

SNN Hedge Fund Activity

We have seen 98 institutional investors add shares of SNN stock to their portfolio, and 107 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles